Austin, CA, United States of America

Michael S Zamloot

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 5.3

ph-index = 8

Forward Citations = 235(Granted Patents)


Location History:

  • Austin, CA (US) (2017)
  • Hillsborough, CA (US) (2013 - 2019)
  • Austin, TX (US) (2015 - 2024)

Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):Explore Patents

Title: Unveiling the Innovative Mind of Michael S Zamloot

Introduction:

Meet the prolific inventor, Michael S Zamloot, hailing from Austin, CA (US), whose intellect has led to the development of 20 groundbreaking patents.

Latest Patents:

1. Solid polymorphs of a FLNA-binding compound and its hydrochloride salts: Zamloot's research delves into the crystalline polymorphs and solvates of various compounds, paving the way for pharmaceutical compositions with enhanced properties.

2. Cocrystals of naloxone and naltrexone: His inventive cocrystals of naloxone and naltrexone offer new possibilities as opioid antagonists, including applications in transdermal patches for effective pain management.

Career Highlights:

With a remarkable career, Zamloot has contributed his expertise to renowned companies such as Durect Corporation and Pain Therapeutics, Inc., excelling in the realm of pharmaceutical innovations.

Collaborations:

Collaborating with esteemed individuals like Su Il Yum and Roger Fu, Zamloot has blended his creative flair with the expertise of his peers, leading to the development of cutting-edge solutions in the pharmaceutical industry.

Conclusion:

In conclusion, Michael S Zamloot's ingenuity and dedication shine through his impressive portfolio of patents, marking him as a trailblazer in the field of pharmaceutical inventions. His collaborative spirit and tireless pursuit of innovation continue to inspire advancements in pain management and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…